Albany, NY -- (SBWIRE) -- 10/12/2017 -- Medical Devices sector report, Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2017" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1326349

Scope

- Extensive coverage of the Point-of-Care (POC) Analyzers under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the products current stage of development, territory and estimated launch date

Browse Detail Report With TOC @ https://www.researchmoz.us/point-of-care-poc-analyzers-medical-devices-pipeline-assessment-2017-report.html

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9

2 Introduction 10
2.1 Point-of-Care (POC) Analyzers Overview 10

3 Products under Development 11
3.1 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
3.2 Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
3.3 Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
3.4 Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
3.5 Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15

4 Point-of-Care (POC) Analyzers - Pipeline Products under Development by Companies 16
4.1 Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 16
4.2 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 18

5 Point-of-Care (POC) Analyzers Companies and Product Overview 20
5.1 Akers Biosciences Inc Company Overview 20
5.1.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 Akonni Biosystems Inc Company Overview 22
5.2.1 Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Alere Inc Company Overview 23
5.3.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 Amplino B.V. Company Overview 24
5.4.1 Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Analytical Diagnostic Solutions Inc Company Overview 25
5.5.1 Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 ApoCell Inc Company Overview 26
5.6.1 ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Aquila Diagnostic Systems Inc. Company Overview 27
5.7.1 Aquila Diagnostic Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.8 Atonomics A/S Company Overview 28
5.8.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 Attophotonics Biosciences GmbH Company Overview 29
5.9.1 Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
5.10 Beckman Coulter Inc Company Overview 30
5.10.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 Binghamton University Company Overview 31
5.11.1 Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Bio-Alternative Medical Devices Ltd Company Overview 32
5.12.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 BioMedomics Inc Company Overview 33
5.13.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.14 bioMerieux S.A. Company Overview 35
5.14.1 bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 Biopico Systems Inc. Company Overview 36
5.15.1 Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.16 Boston University Company Overview 37
5.16.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 37
5.17 CardioGenics Inc Company Overview 39
5.17.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.18 Cepheid Company Overview 40
5.18.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 40
5.19 ChipCare Corp Company Overview 44
5.19.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 City, University of London Company Overview 45
5.20.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 45

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=1326349